MURA - Mural Oncology plc Company Long-Term Liabilities

Public company logo of muraloncology.com (MURA)

Mural Oncology plc (MURA) focuses on developing targeted interleukins to combat solid tumors, leveraging a robust financial foundation and extensive patent protection. This daily price chart confirms current performance, where the metric stands at 0.00. Mural Oncology plc (MURA) concentrates on identifying methods to activate immunity against tumors, while effectively outsourcing clinical trials to international operators to mitigate operational risks.

Mural Oncology plc (MURA) Company Long-Term Debt: for the period 02/21/2024 - 12/20/2025

Mural Oncology (MURA) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Mural Oncology PLC|MURA - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Mural Oncology|MURA - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Mural Oncology|MURA - Company Book Value|Market Value to Book Value muraloncology.com|MURA - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Mural Oncology plc|MURA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Mural Oncology PLC|MURA - Company Total Debt|Debts to Book Capitalization Mural Oncology|MURA - Company Long-Term Debt|Company Short-Term Loans and Borrowings Mural Oncology|Immediate Liquidity muraloncology.com
- earnings and market multiples details:
MURA - Company Net Income
Fundamental company valuation:MURA (Mural Oncology plc)
Brand item of Mural Bio

For Mural Oncology plc (MURA), which invests in the development of high-margin interleukins, the organization's long-term financial debt of 0.00 reflects the volume of resources raised to protect its patent portfolio. This indicator aggregates obligations with a maturity of more than one year, allowing investors to assess default risk and avoid overpaying for an asset with an excessive credit load.

Competitors of Mural Oncology plc (MURA)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debt TuHURA Biosciences, Inc. (HURA)|Company Long-Term Liabilities protaratx.com TARA|Fate Therapeutics - Company Long-Term Liabilities|Company Long-Term Debts Aadi Bioscience, Inc. WHWK|TCRX - Company Long-Term Debt|Company Long-Term Loans and Borrowings CSBR (Champions Oncology)|XBIT: Company Long-Term Debts|CEL-SCI (CVM) - Company Long-Term Debts|Company Long-Term Debt OS Therapies|Company Long-Term Debt RADX|Company Long-Term Liabilities ARTV (Artiva Biotherapeutics, Inc.)|ANL (adlainortye.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Veru Inc. VERU|tempesttx.com (TPST) - Long-Term Debt|XLO - Company Long-Term Debt|RENB (Renovaro Inc.) - Company Long-Term Indebtedness|KAPA: Company Long-Term Debts|Company Long-Term Liabilities OnKure Therapeutics|Company Long-Term Debt CytoMed Therapeutics Ltd|Long-Term Debt Curis Corp CRIS|Company Long-Term Debt Apollomics, Inc. (APLM)|Company Long-Term Debt THAR (Tharimmune Inc)|Company Long-Term Debt Advanced Biomed ADVB|Genprex Inc (GNPX) - Long-Term Debt|Calidi Bio - Company Long-Term Debts|Long-Term Indebtedness Sunshine Biopharma Inc. (SBFM)|XBIO (xeneticbio.com) - Company Long-Term Liabilities|Long-Term Debt Salarius Pharmaceuticals Inc (SLRX)|Company Long-Term Liabilities PPBT|AONC: Company Long-Term Loans and Borrowings|Company Long-Term Debt BeiGene, Ltd. (BGNE)|CKPT: Long-Term Liabilities|Company Long-Term Debt Elevation Oncology, Inc. ELEV|iCAD Inc. - Company Long-Term Debt|Ikena - Company Long-Term Debts|Notable Labs Corp (NTBL) - Company Long-Term Liabilities|viracta.com (VIRX) - Company Long-Term Debt|Company Long-Term Liabilities morphosys.com|Company Long-Term Liabilities NAYA|Company Long-Term Debts Ascentage Pharma Group International